Your browser doesn't support javascript.
loading
Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer.
Shi, Wenjie; Wan, Xinyu; Wang, Ye; He, Jinzhi; Huang, Xiaofeng; Xu, Yinggang; Zhang, Weiwei; Chen, Rui; Wang, Lexin; Zheng, Ran; Ma, Lingjun; Li, Xuan; Xu, Lu; Zha, Xiaoming; Wang, Jue.
Afiliação
  • Shi W; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: shiwenjie61@163.com.
  • Wan X; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: 269523263@qq.com.
  • Wang Y; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: 941068499@qq.com.
  • He J; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: 13952174709@163.com.
  • Huang X; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: hxfeng_a@163.com.
  • Xu Y; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: 15651781716@163.com.
  • Zhang W; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: 229785951@qq.com.
  • Chen R; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: 15951756315@163.com.
  • Wang L; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: lexin_wang0312@163.com.
  • Zheng R; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: 15705227155@163.com.
  • Ma L; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: malingjun0130@126.com.
  • Li X; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: lilixuannn@163.com.
  • Xu L; Department of Clinical Nutrition, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: lulu-x-u@163.com.
  • Zha X; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: njzhaxm@njmu.edu.cn.
  • Wang J; Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing 210000, China. Electronic address: wangjue200011@njmu.edu.cn.
Nanomedicine ; 49: 102666, 2023 04.
Article em En | MEDLINE | ID: mdl-36889422

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Nanopartículas Limite: Female / Humans Idioma: En Revista: Nanomedicine Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Nanopartículas Limite: Female / Humans Idioma: En Revista: Nanomedicine Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2023 Tipo de documento: Article